Eric M Dube insider trades

Open-market stock purchases and sales by Eric M Dube, CHIEF EXECUTIVE OFFICER at Travere Therapeutics, Inc, from SEC Form 4 filings since Jan 4, 2019.

Recent trades

DateStockTradeValue
Sep 17, 2026TVTX Travere Therapeutics, IncSold$6.6M
Sep 17, 2026TVTX Travere Therapeutics, IncSold$442K
Sep 17, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 16, 2026TVTX Travere Therapeutics, IncSold$6.3M
Sep 16, 2026TVTX Travere Therapeutics, IncSold$6.1M
Sep 16, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Sep 15, 2026TVTX Travere Therapeutics, IncSold$3.9M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$1.8M
Sep 15, 2026TVTX Travere Therapeutics, IncSold$197K
Sep 15, 2026TVTX Travere Therapeutics, IncSold$17.6K
Sep 15, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 6, 2026TVTX Travere Therapeutics, IncSold$989K
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
May 4, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 15, 2026TVTX Travere Therapeutics, IncSold$2.3M
Apr 15, 2026TVTX Travere Therapeutics, IncSold$299K
Apr 15, 2026TVTX Travere Therapeutics, IncSold$853
Apr 13, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Apr 1, 2026TVTX Travere Therapeutics, IncSold$1.1M
Apr 1, 2026TVTX Travere Therapeutics, IncSold$790K
Apr 1, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Feb 20, 2026TVTX Travere Therapeutics, IncBought (not open market)—
Feb 20, 2026TVTX Travere Therapeutics, IncSold$1.8M
Feb 3, 2026TVTX Travere Therapeutics, IncSold$2.1M
Feb 3, 2026TVTX Travere Therapeutics, IncSold$1.1M

Companies traded

  • TVTX Travere Therapeutics, Inc: 49 sales, last Sep 17, 2026
  • RPHM Reneo Pharmaceuticals, Inc: other filings, last Jun 6, 2023
  • RTRX Retrophin, Inc: 4 sales, last Sep 21, 2020

Get free alerts when Eric M Dube files a new trade →